معرفی
Dr. Yadollah Omidi is a full professor of pharmaceutical sciences at the Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale/Davie, USA. With over 330 peer-reviewed publications, 30 book chapters, and an h-index of 65, he is recognized among the top 1% of scientists worldwide by ESI-WoS. Dr. Omidi has extensive experience in drug delivery, nanomedicine, and targeting, with a particular emphasis on cancer therapy, vaccines, diagnostics, and nanobiomaterials. He has served as the founding Editor-in-Chief of Bioimpacts and is on the editorial boards of several high-impact journals including Nanomedicine, Biologicals, and BMC Pharmacology and Toxicology.
- Pharm.D. – Tabriz University of Medical Sciences, Iran (1991)
- Ph.D. – Cardiff University, United Kingdom (2003)
- Postdoctoral Research Associate – Cardiff University School of Pharmacy
Research Interests include:
- Drug Delivery and Targeting
- Multifunctional Nanomedicines
- Theranostics
- Biological Membranes and Barriers
- Vaccines and Immunotherapeutics
- Nanobiomaterials for Regenerative Medicine
- Diagnostic Nanobiosystems
Recent Publications focus on:
- mRNA and self-amplifying mRNA vaccine nanoformulations
- Therapeutic applications of chitosan-based nanocarriers
- Use of Janus nanoparticles in multimodal cancer therapy
- Blockchain in pharmaceutical lifecycle management
- Hydrogels in targeted and sustained drug release
- Multi-functional nanomaterials in diagnostics and therapy
Scientific Recognition:
- Top 1% Scientist – ESI-WoS
- h-index: 65
- i10-index: 251
- Total citations: 14,550
- Recipient of multiple research and teaching awards
Academic Leadership:
- Founding Director of the TUOMS Research Center for Pharmaceutical Nanotechnology
- Founding Editor-in-Chief of Bioimpacts
- Editorial Board Member – Nanomedicine, Biologicals, DARU Journal, BMC Pharmacology and Toxicology
- Collaborator with international scientists – USA, Europe
